Northern Trust Corp Fennec Pharmaceuticals Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 139,731 shares of FENC stock, worth $836,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares

139,731

Previous 106,399 31.33%

Holding current value

$836,988

Previous $650,000 7.38%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.85 - $6.73 $161,660 - $224,324	33,332 Added 31.33%	139,731 $698,000
Q2 2024 Aug 14, 2024	SELL	$6.02 - $10.99 $46,167 - $84,282	-7,669 Reduced 6.72%	106,399 $650,000
Q1 2024 May 14, 2024	BUY	$8.82 - $11.12 $20,356 - $25,664	2,308 Added 2.07%	114,068 $1.27 Million
Q4 2023 Feb 13, 2024	BUY	$6.48 - $11.61 $5,812 - $10,414	897 Added 0.81%	111,760 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$7.15 - $8.94 $25,883 - $32,362	-3,620 Reduced 3.16%	110,863 $832,000
Q2 2023 Aug 11, 2023	BUY	$7.27 - $9.82 $832,291 - $1.12 Million	114,483 New	114,483 $1.01 Million
Q2 2021 Aug 13, 2021	SELL	$5.96 - $7.85 $1.09 Million - $1.43 Million	-182,107 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$6.21 - $8.68 $135,949 - $190,022	-21,892 Reduced 10.73%	182,107 $1.13 Million
Q4 2020 Feb 11, 2021	SELL	$5.99 - $8.55 $15,783 - $22,529	-2,635 Reduced 1.28%	203,999 $1.52 Million
Q3 2020 Nov 16, 2020	SELL	$5.19 - $10.17 $53,072 - $103,998	-10,226 Reduced 4.72%	206,634 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $1.18 Million - $2.04 Million	216,860 New	216,860 $1.81 Million
Q3 2019 Nov 13, 2019	SELL	$3.85 - $4.95 $373,342 - $480,011	-96,972 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$3.3 - $5.09 $16,846 - $25,984	-5,105 Reduced 5.0%	96,972 $388,000
Q1 2019 May 13, 2019	BUY	$4.64 - $7.58 $1,020 - $1,667	220 Added 0.22%	102,077 $495,000
Q4 2018 Feb 12, 2019	SELL	$5.37 - $8.39 $1,224 - $1,912	-228 Reduced 0.22%	101,857 $650,000
Q3 2018 Nov 14, 2018	BUY	$7.84 - $10.83 $5,903 - $8,154	753 Added 0.74%	102,085 $837,000
Q2 2018 Aug 14, 2018	BUY	$10.05 - $14.33 $1.02 Million - $1.45 Million	101,332 New	101,332 $1.06 Million

Others Institutions Holding FENC

# of Institutions

Shares Held

14.9M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $156M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Fennec Pharmaceuticals Inc. Transaction History